CLEANING COMPOUND, ULTRASONIC, DENTAL

The contract calls for the supply of 2 boxes of Maxizyme enzyme cleaning tablets, an ultrasonic dental cleaning compound, with each box containing 64 tablets, for a total value of $77.08. Delivery is required within five days after order placement to the Carrier Outfitting Material Support Center in Suffolk, Virginia, under FOB Destination terms. The product must be packaged commercially in sealed unit containers that protect against damage and breakage, with exterior shipping containers suitable for safe delivery via common carrier at the lowest rate. All packaging and labeling must comply with Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions, and includes mandatory machine-readable barcoding for shipment identification. The item is subject to DLA’s Master List of Technical and Quality Requirements, and must meet applicable hazardous materials handling standards under OSHA’s Hazard Communication Standard, with proper labeling and documentation required. The contract is governed by a firm-fixed-price structure under the Federal Acquisition Regulation with multiple clauses addressing supply inspection at the destination, safeguarding of government information, cybersecurity, trafficking in persons, employment eligibility verification, sustainable products, and prohibitions on certain materials like hexavalent chromium. Invoicing must be processed electronically through WAWF, and the contractor must provide a Unique Entity ID and CAGE code. The solicitation was issued by the Defense Logistics Agency’s Medical Supply Chain FSH, with a response deadline of August 6, 2026, and includes clauses requiring representation of small business status, whistleblower rights, and compliance with restrictions on covered defense telecommunications equipment. The contract imposes no options or indefinite delivery requirements beyond the two-box requirement.